Safra Catz - 12 Apr 2023 Form 4 Insider Report for ORACLE CORP (ORCL)

Role
Chief Executive Officer, Director
Signature
/s/ Rebecca A. Isakson by Rebecca A. Isakson, Attorney in Fact for Safra Catz (POA Filed 03-21-19)
Issuer symbol
ORCL
Transactions as of
12 Apr 2023
Net transactions value
-$123,626,282
Form type
4
Filing time
13 Apr 2023, 20:34:18 UTC
Previous filing
12 Apr 2023
Next filing
05 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORCL Common Stock Options Exercise $57,933,386 +1,924,058 +172% $30.11 3,042,650 12 Apr 2023 Direct
transaction ORCL Common Stock Sale $112,735,087 -1,198,417 -39% $94.07 1,844,233 12 Apr 2023 Direct F1, F2
transaction ORCL Common Stock Sale $68,824,582 -725,641 -39% $94.85 1,118,592 12 Apr 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORCL Stock Option Options Exercise $0 -1,924,058 -100% $0.000000* 0 12 Apr 2023 Common Stock 1,924,058 $30.11 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 9, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $93.595 to $94.59. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $94.595 to $95.3050. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F4 25% of the shares subject to the option vested annually on each anniversary of the grant date.